BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17094447)

  • 1. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
    Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
    Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles.
    Lin R; Shi Ng L; Wang CH
    Biomaterials; 2005 Jul; 26(21):4476-85. PubMed ID: 15701377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma.
    Ranganath SH; Wang CH
    Biomaterials; 2008 Jul; 29(20):2996-3003. PubMed ID: 18423584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
    Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
    J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new polymer-based particulate systems for anti-glioma vaccination.
    Sapin A; Garcion E; Clavreul A; Lagarce F; Benoit JP; Menei P
    Int J Pharm; 2006 Feb; 309(1-2):1-5. PubMed ID: 16386390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain.
    Khan A; Sommer W; Fuxe K; Akhtar S
    J Drug Target; 2000; 8(5):319-34. PubMed ID: 11328659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fabrication of double-walled microspheres for the sustained release of doxorubicin.
    Tan EC; Lin R; Wang CH
    J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres.
    Yemisci M; Bozdag S; Cetin M; Söylemezoglu F; Capan Y; Dalkara T; Vural I
    Neurosurgery; 2006 Dec; 59(6):1296-302; discussion 1302-3. PubMed ID: 17277693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of interleukin-18-loaded biodegradable microspheres.
    Lagarce F; Garcion E; Faisant N; Thomas O; Kanaujia P; Menei P; Benoit JP
    Int J Pharm; 2006 May; 314(2):179-88. PubMed ID: 16515850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous delivery of endogenous inhibitors from poly(lactic-co-glycolic acid) polymeric microspheres inhibits glioma tumor growth.
    Benny O; Duvshani-Eshet M; Cargioli T; Bello L; Bikfalvi A; Carroll RS; Machluf M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):768-76. PubMed ID: 15701867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives.
    Mundargi RC; Babu VR; Rangaswamy V; Patel P; Aminabhavi TM
    J Control Release; 2008 Feb; 125(3):193-209. PubMed ID: 18083265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled degradation of multilayered poly(lactide-co-glycolide) films using electron beam irradiation.
    Chia NK; Venkatraman SS; Boey FY; Cadart S; Loo JS
    J Biomed Mater Res A; 2008 Mar; 84(4):980-7. PubMed ID: 17647238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
    Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
    Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabrication of multi-layered biodegradable drug delivery device based on micro-structuring of PLGA polymers.
    Ryu WH; Vyakarnam M; Greco RS; Prinz FB; Fasching RJ
    Biomed Microdevices; 2007 Dec; 9(6):845-53. PubMed ID: 17577671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment.
    Weinberg BD; Blanco E; Lempka SF; Anderson JM; Exner AA; Gao J
    J Biomed Mater Res A; 2007 Apr; 81(1):205-13. PubMed ID: 17120205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum.
    Kohane DS; Tse JY; Yeo Y; Padera R; Shubina M; Langer R
    J Biomed Mater Res A; 2006 May; 77(2):351-61. PubMed ID: 16425240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug delivery into the brain using poly(lactide-co-glycolide) microspheres.
    Menei P; Montero-Menei C; Venier MC; Benoit JP
    Expert Opin Drug Deliv; 2005 Mar; 2(2):363-76. PubMed ID: 16296760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designing bioresorbable polyester matrices for controlled doxorubicin release in glioma therapy.
    Kasperczyk J; Stoklosa K; Dobrzynski P; Stepien K; Kaczmarczyk B; Dzierzega-Lecznar A
    Int J Pharm; 2009 Dec; 382(1-2):124-9. PubMed ID: 19715746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.